Dynavax Technologies
DVAX
$11.56
Share price
-1.11%
Change (1 day)
2.76%
Change (1 year)
Categories
Dynavax Technologies (DVAX) Fails to deliver data
Key failure to deliver metrics for Dynavax Technologies :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.11 M
- Last 3 months FTD volume: $0.36 M
- Last year FTD volume: $2.5 M
Failures to deliver for Dynavax Technologies (DVAX) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Dynavax Technologies (DVAX) - since 2014
Volume in USD (price x number of shares), data since 2014Dynavax Technologies (DVAX) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.36 M | -96.11% |
| 2023 | $9.46 M | -85.84% |
| 2022 | $66.82 M | 108.46% |
| 2021 | $32.05 M | -17.88% |
| 2020 | $39.03 M | 10.44% |
| 2019 | $35.34 M | 148.8% |
| 2018 | $14.2 M | -54.86% |
| 2017 | $31.46 M | 4.28% |
| 2016 | $30.17 M | 37.8% |
| 2015 | $21.9 M | 108.04% |
| 2014 | $10.52 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Pfizer PFE | $31.87 M | $0.32 B | 🇺🇸 USA |
 Amgen AMGN | $65.7 M | $0.18 B | 🇺🇸 USA |
 Biogen BIIB | $17.8 M | $72.14 M | 🇺🇸 USA |
 Gilead Sciences GILD | $49.76 M | $0.27 B | 🇺🇸 USA |
 Merck MRK | $8.48 M | $0.18 B | 🇺🇸 USA |
 AstraZeneca AZN | $0.10 B | $0.17 B | 🇬🇧 UK |
 GlaxoSmithKline GSK | $15.53 M | $26.02 M | 🇬🇧 UK |
 Agenus
AGEN | $3.33 M | $6.35 M | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $6.66 M | $42.47 M | 🇮🇱 Israel |